Strategies to minimize intraoperative blood loss during major surgery

British Journal of Surgery

Volumn 107, Issue 2, 2020, Pages e26-e38

  Shah, A ^a,b   Palmer, A J R ^a   Klein, A A ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; APIXABAN; APROTININ; DABIGATRAN; DESMOPRESSIN; DEXMEDETOMIDINE; EDOXABAN; ESMOLOL; GLYCERYL TRINITRATE; HEPARIN; PROPOFOL; PROTHROMBIN COMPLEX; REMIFENTANIL; RIVAROXABAN; TRANEXAMIC ACID;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING RISK SCORE; BLOOD CLOTTING; BLOOD FLOW; BLOOD SALVAGE; BLOOD TRANSFUSION; BLOOD VOLUME; COST EFFECTIVENESS ANALYSIS; CREATININE CLEARANCE; DIATHERMY; DRUG SAFETY; EPIDURAL ANESTHESIA; HEART OUTPUT; HEMOSTASIS; HYDROSTATIC PRESSURE; HYPOTHERMIA; IMMUNOMODULATION; KIDNEY FUNCTION; OPERATION DURATION; OPERATIVE BLOOD LOSS; PARTIAL THROMBOPLASTIN TIME; PATIENT POSITIONING; PLASMINOGEN ACTIVATION; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SURGICAL STRESS; THROMBOELASTOGRAPHY; THROMBOSIS; VENOUS THROMBOEMBOLISM; ADVERSE EVENT; BLOODLESS CARE; HEMOSTATIC TECHNIQUE; HUMAN; INTRAOPERATIVE PERIOD; PROCEDURES; SURGERY;

BLOOD LOSS, SURGICAL; BLOODLESS MEDICAL AND SURGICAL PROCEDURES; HEMOSTATIC TECHNIQUES; HUMANS; INTRAOPERATIVE PERIOD; SURGICAL PROCEDURES, OPERATIVE;

EID: 85077328154     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.11393     Document Type: Review

References (126)

1. Meara JG, Leather AJ, Hagander L, Aikire BC, Alonson N, Ameh EA et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Surgery 2015; 158: 3–6.
2. Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A; National Institute for Health Research Global Health Research Unit on Global Surgery. Global burden of postoperative death. Lancet 2019; 393: 401.
3. International Surgical Outcomes Study. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth 2016; 117: 601–609.
4. Biccard BM, Madiba TE, Kluyts HL, Munlemvo DM, Madzimbamuto FD, Basenero A et al. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet 2018; 391: 1589–1598.
5. Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 2010; 252: 11–17.
6. Smilowitz NR, Oberweis BS, Nukala S, Rosenberg A, Zhao S, Xu J et al. Association between anemia, bleeding, and transfusion with long-term mortality following noncardiac surgery. Am J Med 2016; 129: 315–323.e2.
7. Christensen MC, Dziewior F, Kempel A, von Heymann C. Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26: 46–51.
8. Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011; 11: 135.
9. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000; 28: 451–457.
10. Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113: 1319–1333.
11. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005; 129: 307–321.
12. Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia 2015; 70(Suppl 1): 96–101.
13. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma 2009; 67: 202–209.
14. Clevenger B, Mallett SV, Klein AA, Richards T. Patient blood management to reduce surgical risk. Br J Surg 2015; 102: 1325–1337.
15. Munting KE, Klein AA. Optimisation of pre-operative anaemia in patients before elective major surgery – why, who, when and how? Anaesthesia 2019; 74(Suppl 1): 49–57.
16. Gill R. Practical management of major blood loss. Anaesthesia 2015; 70(Suppl 1): 54–57.
17. Curry NS, Davenport R. Transfusion strategies for major haemorrhage in trauma. Br J Haematol 2019; 184: 508–523.
18. Muñoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233–247.
19. Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R et al. Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA 2019; 321: 983–997.
20. Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 2008; 140: 496–504.
21. Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2017; 34: 332–395.
22. Shah A, Stanworth SJ, McKechnie S. Evidence and triggers for the transfusion of blood and blood products. Anaesthesia 2015; 70: 10–19.
23. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063–2065.
24. Rodeghiero F, Castaman G, Tosetto A, Battle J, Baudo F, Cappelletti A et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619–2626.
25. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418–1421.
26. Sramek A, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155: 1409–1415.
27. Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011; 39: 924–930.
28. Greiff G, Pleym H, Stenseth R, Berg KS, Wahba A, Videm V. Prediction of bleeding after cardiac surgery: comparison of model performances: a prospective observational study. J Cardiothorac Vasc Anesth 2015; 29: 311–319.
29. Klein AA, Collier T, Yeates J, Miles LF, Fletcher SN, Evans C et al. The ACTA PORT-score for predicting perioperative risk of blood transfusion for adult cardiac surgery. Br J Anaesth 2017; 119: 394–401.
30. van Veen JJ, Makris M. Management of peri-operative anti-thrombotic therapy. Anaesthesia 2015; 70(Suppl 1): 58–67.
31. Keeling D, Tait RC, Watson H; British Committee of Standards for Haematology. Peri-operative management of anticoagulation and antiplatelet therapy. Br J Haematol 2016; 175: 602–613.
32. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016; 68: 1082–1115.
33. Douketis JD, Hasselblad V, Ortel TL. Bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 2016; 374: 93–94.
34. Zhang W, Li N, Chen S, Tan Y, Al-Aidaros M, Chen L. The effects of a tourniquet used in total knee arthroplasty: a meta-analysis. J Orthop Surg Res 2014; 9: 13.
35. Smith TO, Hing CB. Is a tourniquet beneficial in total knee replacement surgery? A meta-analysis and systematic review. Knee 2010; 17: 141–147.
36. Schnettler T, Papillon N, Rees H. Use of a tourniquet in total knee arthroplasty causes a paradoxical increase in total blood loss. J Bone Joint Surg Am 2017; 99: 1331–1336.
37. Palmer A, Chen A, Matsumoto T, Murphy M, Price A. Blood management in total knee arthroplasty: state-of-the-art review. J ISAKOS 2018; 3: 358–366.
38. Liu D, Graham D, Gillies K, Gillies RM. Effects of tourniquet use on quadriceps function and pain in total knee arthroplasty. Knee Surg Relat Res 2014; 26: 207–213.
39. Huang Z, Xie X, Li L, Huang Q, Ma J, Shen B et al. Intravenous and topical tranexamic acid alone are superior to tourniquet use for primary total knee arthroplasty: a prospective, randomized controlled trial. J Bone Joint Surg Am 2017; 99: 2053–2061.
40. Padhi S, Kemmis-Betty S, Rajesh S, Hill J, Murphy MF. Blood transfusion: summary of NICE guidance. BMJ 2015; 351: h5832.
41. Gerstein NS, Brierley JK, Windsor J, Pannikath PV, Ram H, Gelfenbeyn et al. Antifibrinolytic agents in cardiac and noncardiac surgery: a comprehensive overview and update. J Cardiothorac Vasc Anesth 2017; 31: 2183–2205.
42. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319–2331.
43. Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014; 349: g4829.
44. Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S et al. Safety of intravenous tranexamic acid in patients undergoing major orthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus 2018; 16: 36–43.
45. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 2013; 100: 1271–1279.
46. Dai Z, Chu H, Wang S, Liang Y. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: a systematic review and cumulative meta-analysis. J Clin Anesth 2018; 44: 23–31.
47. Cheriyan T, Maier SP, Bianco K, Slobodyanyuk K, Rattenni RN, Lafage V et al. Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J 2015; 15: 752–761.
48. Amer KM, Rehman S, Amer K, Haydel C. Efficacy and safety of tranexamic acid in orthopaedic fracture surgery: a meta-analysis and systematic literature review. J Orthop Trauma 2017; 31: 520–525.
49. Longo MA, Cavalheiro BT, de Oliveira Filho GR. Systematic review and meta-analyses of tranexamic acid use for bleeding reduction in prostate surgery. J Clin Anesth 2018; 48: 32–38.
50. Topsoee MF, Settnes A, Ottesen B, Bergholt T. A systematic review and meta-analysis of the effect of prophylactic tranexamic acid treatment in major benign uterine surgery. Int J Gynaecol Obstet 2017; 136: 120–127.
51. Murphy GR, Glass GE, Jain A. The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery. J Craniofac Surg 2016; 27: 374–379.
52. Gibbs VN, Champaneria R, Palmer A, Doree C, Estcourt LJ. Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis. Cochrane Database Syst Rev 2019; (3)CD013295.
53. Montroy J, Fergusson NA, Hutton B, Lavallee LT, Morash C, Cagiannos I et al. The safety and efficacy of lysine analogues in cancer patients: a systematic review and meta-analysis. Transfus Med Rev 2017; 31: 141–148.
54. Klein AA, Arnold P, Bingham RM, Brohi K, Clark R, Collis R et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71: 829–842.
55. Klein AA, Bailey CR, Charlton AJ, Evans E, Guckian-Fisher M, McCrossan R et al. Association of anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018; 73: 1141–1150.
56. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; (4)CD001888.
57. Meybohm P, Choorapoikayil S, Wessels A, Herrmann E, Zacharowski K, Spahn DR. Washed cell salvage in surgical patients: a review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore) 2016; 95: e4490.
58. Chakladar A, Fludder V, Sugavanam A. Association of Anaesthetists recommendations for cell salvage in obstetric anaesthesia. Anaesthesia 2018; 73: 1575–1576.
59. Khan KS, Moore PAS, Wilson MJ, Hooper R, Allard S, Wrench I et al. Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO). PLoS Med 2017; 14: e1002471.
60. Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology 2003; 99: 652–655.
61. Kim JL, Park JH, Han SB, Cho IY, Jang KM. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty 2017; 32: 320–325.
62. Kumar N, Zaw AS, Kantharajanna SB, Khoo BL, Lim CT, Thiery JP. Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? Transfus Med 2017; 27(Suppl 5): 327–334.
63. Morton JM, Rahn KA, Shugart RM, Wojdyla JM. Does mechanical filtration of intraoperative cell salvage effectively remove titanium debris generated during instrumented spinal surgery? An in vitro analysis. Spine J 2014; 14: 3011–3017.
64. Witzigmann H, Diener MK, Kienkotter S, Rossion I, Brucker T, Werner B et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). Ann Surg 2016; 264: 528–537.
65. Denost Q, Rouanet P, Faucheron JL, Panis Y, Meunier B, Cotte E et al. To drain or not to drain infraperitoneal anastomosis after rectal excision for cancer: the GRECCAR 5 randomized trial. Ann Surg 2017; 265: 474–480.
66. Khan SM, Smeulders MJ, Van der Horst CM. Wound drainage after plastic and reconstructive surgery of the breast. Cochrane Database Syst Rev 2015; (10)CD007258.
67. Charoenkwan K, Kietpeerakool C. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies. Cochrane Database Syst Rev 2017; (6)CD007387.
68. Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 2007; (3)CD001825.
69. Pan JK, Hong KH, Xie H, Luo MH, Guo D, Liu J. The efficacy and safety of autologous blood transfusion drainage in patients undergoing total knee arthroplasty: a meta-analysis of 16 randomized controlled trials. BMC Musculoskelet Disord 2016; 17: 452.
70. Horstmann W, Kuipers B, Ohanis D, Slappendel R, Kollen B, Verheyen C. Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial. Blood Transfus 2014; 12(Suppl 1): s176–s181.
71. Simillis C, Lal N, Thoukididou SN, Kontovounisios C, Smith JJ, Hompes R et al. Open versus laparoscopic versus robotic versus transanal mesorectal excision for rectal cancer: a systematic review and network meta-analysis. Ann Surg 2019; 270: 59–68.
72. Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 2016; 388: 1057–1066.
73. van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 2019; 269: 621–630.
74. Gavriilidis P, Roberts KJ, Sutcliffe RP. Comparison of robotic vs laparoscopic vs open distal pancreatectomy. A systematic review and network meta-analysis: HPB (Oxford), 2019; doi: 10.1016/j.hpb.2019.04.010 [Epub ahead of print].
75. Han SB, Kim HJ, Kim TK, In Y, Oh KJ, Koh IJ et al. Computer navigation is effective in reducing blood loss but has no effect on transfusion requirement following primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2016; 24: 3474–3481.
76. Li YC, Chao A, Yang LY, Huang HY, Huang YT, Kuo HH et al. Electrothermal bipolar vessel sealing device (LigaSure) versus conventional diathermy in laparoscopic myomectomy: a propensity-matched analysis. PLoS One 2018; 13: e0193611.
77. Polychronidis G, Huttner FJ, Contin P, Goossen K, Uhlmann L, Heidmann M et al. Network meta-analysis of topical haemostatic agents in thyroid surgery. Br J Surg 2018; 105: 1573–1582.
78. Brustia R, Granger B, Scatton O. An update on topical haemostatic agents in liver surgery: systematic review and meta analysis. J Hepatobiliary Pancreat Sci 2016; 23: 609–621.
79. Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 2008; 37: 687–703.
80. Albertin A, La Colla L, Gandolfi A, Colnaghi E, Mandelli D, Giola G et al. Greater peripheral blood flow but less bleeding with propofol versus sevoflurane during spine surgery: a possible physiologic model? Spine (Phila Pa 1976) 2008; 33: 2017–2022.
81. Boldt J, Weber A, Mailer K, Papsdorf M, Schuster P. Acute normovolaemic haemodilution vs controlled hypotension for reducing the use of allogeneic blood in patients undergoing radical prostatectomy. Br J Anaesth 1999; 82: 170–174.
82. Boonmak P, Boonmak S, Laopaiboon M. Deliberate hypotension with propofol under anaesthesia for functional endoscopic sinus surgery (FESS). Cochrane Database Syst Rev 2016; (10)CD006623.
83. Paul JE, Ling E, Lalonde C, Thabane L. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 2007; 54: 799–810.
84. Moraca RJ, Sheldon DG, Thirlby RC. The role of epidural anesthesia and analgesia in surgical practice. Ann Surg 2003; 238: 663–673.
85. Rosenfeld BA, Beattie C, Christopherson R, Norris EJ, Frank SM, Breslow MJ et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 79: 435–443.
86. Richman JM, Rowlingson AJ, Maine DN, Courpas GE, Weller JF, Wu CL. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth 2006; 18: 427–435.
87. Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 2006; 103: 1018–1025.
88. Macfarlane AJ, Prasad GA, Chan VW, Brull R. Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res 2009; 467: 2379–2402.
89. Smith LM, Cozowicz C, Uda Y, Memtsoudis SG, Barrington MJ. Neuraxial and combined neuraxial/general anesthesia compared to general anesthesia for major truncal and lower limb surgery: a systematic review and meta-analysis. Anesth Analg 2017; 125: 1931–1945.
90. Edgcombe H, Carter K, Yarrow S. Anaesthesia in the prone position. Br J Anaesth 2008; 100: 165–183.
91. Park CK. The effect of patient positioning on intraabdominal pressure and blood loss in spinal surgery. Anesth Analg 2000; 91: 552–557.
92. Ko MT, Chuang KC, Su CY. Multiple analyses of factors related to intraoperative blood loss and the role of reverse Trendelenburg position in endoscopic sinus surgery. Laryngoscope 2008; 118: 1687–1691.
93. Widman J, Isacson J. Lateral position reduces blood loss in hip replacement surgery: a prospective randomized study of 74 patients. Int Orthop 2001; 25: 226–227.
94. Reynolds L, Beckmann J, Kurz A. Perioperative complications of hypothermia. Best Pract Res Clin Anaesthesiol 2008; 22: 645–657.
95. Buggy DJ, Crossley AW. Thermoregulation, mild perioperative hypothermia and postanaesthetic shivering. Br J Anaesth 2000; 84: 615–628.
96. Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008; 108: 71–77.
97. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289–292.
98. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334: 1209–1216.
99. Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997; 277: 1127–1134.
100. Lenhardt R, Marker E, Goll V, Tschernich H, Kurz A, Sessler DI et al. Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology 1997; 87: 1318–1323.
101. Harper CM, Andrzejowski JC, Alexander R. NICE and warm. Br J Anaesth 2008; 101: 293–295.
102. Bisbe E, Moltó L. Pillar 2: minimising bleeding and blood loss. Best Pract Res Clin Anaesthesiol 2013; 27: 99–110.
103. Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A et al.; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 2013; 369: 428–437.
104. Neuschwander A, Futier E, Jaber S, Pereira B, Eurin M, Marret E et al. The effects of intraoperative lung protective ventilation with positive end-expiratory pressure on blood loss during hepatic resection surgery: a secondary analysis of data from a published randomised control trial (IMPROVE). Eur J Anaesthesiol 2016; 33: 292–298.
105. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004; 351: 683–694.
106. Spahn DR, Boullion B, Cerny V, Duranteau J, Filipescu D, Hunt BJ et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 2019; 23: 19.
107. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*. Anesthesiology 2015; 122: 241–275.
108. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertlis E, Filipescu DC et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270–382.
109. Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database Syst Rev 2017; (7)CD001884.
110. Desborough MJ, Oakland KA, Landoni G, Crivellari M, Doree C, Estcourt LJ et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost 2017; 15: 263–272.
111. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D. Intensive Care Study of Coagulopathy (ISOC) Investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15: R108.
112. Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51: 62–70.
113. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C et al. Guidelines on oral anticoagulation with warfarin – fourth edition. Br J Haematol 2011; 154: 311–324.
114. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012; (3)CD005011.
115. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012; 99(Suppl 1): 40–50.
116. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Kingler A et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007; 105: 905–917.
117. Ucar HI, Oc M, Tok M, Dogan OF, Oc B, Aydin A et al. Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum 2007; 10: E392–E396.
118. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266–273.
119. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K; British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 2015; 170: 788–803.
120. Morrison GA, Koch J, Royds M, McGee D, Chalmers RTA, Anderson J et al. Fibrinogen concentrate vs. fresh frozen plasma for the management of coagulopathy during thoraco-abdominal aortic aneurysm surgery: a pilot randomised controlled trial. Anaesthesia 2019; 74: 180–189.
121. Fabes J, Brunskill SJ, Curry N, Doree C, Stanworth SJ. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia. Cochrane Database Syst Rev 2018; (12)CD010649.
122. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652–2658.
123. Curry NS, Davenport R, Pavord S, Mallett SV, Kitchen D, Klein AA et al. The use of viscoelastic haemostatic assays in the management of major bleeding: a British Society for Haematology guideline. Br J Haematol 2018; 182: 789–806.
124. Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015; 19: 1–228, v–vi.
125. Collins PW, Cannings-John R, Bruynseels D, Mallaiah S, Dick J, Elton C et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth 2017; 119: 411–421.
126. McNamara H, Kenyon C, Smith R, Mallaiah S, Barclay P. Four years' experience of a ROTEM®-guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia 2019; 74: 984–991.